miRNA-223 is an anticancer gene in human non-small cell lung cancer through the PI3K/AKT pathway by targeting EGFR

The present study aimed to further explore the molecular mechanisms of miRNA-223 in non-small cell lung cancer (NSCLC). Data prospectively collected from NSCLC patients and volunteers from March 2016 to May 2016 at Tsinghua Changgung Hospital were analyzed. Cell proliferation was measured using MTT...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Hui-Ping, Kong, Wei-Xiang, Li, Xiu-Ying, Li, Wei, Zhang, Yan, Wu, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6365711/
https://www.ncbi.nlm.nih.gov/pubmed/30747217
http://dx.doi.org/10.3892/or.2019.6983

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6365711/
https://www.ncbi.nlm.nih.gov/pubmed/30747217
http://dx.doi.org/10.3892/or.2019.6983

Ejemplares similares